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Anabolic-androgenic steroids (AAS) are lipophilic hormones often taken in excessive
quantities by athletes and bodybuilders to enhance performance and increase muscle
mass. AAS exert well known toxic effects on specific cell and tissue types and organ
systems. The attention that androgen abuse has received lately should be used as an
opportunity to educate both athletes and the general population regarding their adverse
effects. Among numerous commercially available steroid hormones, very few have been
specifically tested for direct neurotoxicity. We evaluated the effects of supraphysiological
doses of methandienone and 17-α-methyltestosterone on sympathetic-like neuron cells.
Vitality and apoptotic effects were analyzed, and immunofluorescence staining and
western blot performed. In this study, we demonstrate that exposure of supraphysiological
doses of methandienone and 17-α-methyltestosterone are toxic to the neuron-like
differentiated pheochromocytoma cell line PC12, as confirmed by toxicity on neurite
networks responding to nerve growth factor and the modulation of the survival and
apoptosis-related proteins ERK, caspase-3, poly (ADP-ribose) polymerase and heat-shock
protein 90. We observe, in contrast to some previous reports but in accordance with
others, expression of the androgen receptor (AR) in neuron-like cells, which when inhibited
mitigated the toxic effects of AAS tested, suggesting that the AR could be binding
these steroid hormones to induce genomic effects. We also note elevated transcription
of neuritin in treated cells, a neurotropic factor likely expressed in an attempt to resist
neurotoxicity. Taken together, these results demonstrate that supraphysiological exposure
to the AAS methandienone and 17-α-methyltestosterone exert neurotoxic effects by
an increase in the activity of the intrinsic apoptotic pathway and alterations in neurite
networks.
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INTRODUCTION
Anabolic-androgenic steroids (AAS) are lipophilic hormones,
derived from cholesterol, that include in the same fam-
ily the natural male hormone testosterone, along with the
related molecules methandienone, 17-α-methyltestosterone, nan-
drolone, and androsterone (Orlando et al., 2007). For many
years athletes and bodybuilders have been taking AAS in sup-
raphysiological doses in order to attain greatly increased muscle
mass, well beyond what can be achieved through natural means
(Kouri et al., 1995), without regards to their potentially toxic
side effects. Intake of AAS by athletes and others in an attempt
to gain strength and improve performance is often associated
with toxic effects on the liver, the cardiovascular system and the
Abbreviations: AAS, anabolic-androgenic steroids; CNS, central nervous system;
AR, androgen receptor; PARP, poly (adenosine diphosphate [ADP]-ribose)
polymerase; Hsp, heat shock protein; NGF, nerve growth factor; PC12,
pheochromocytoma 12 cells; EB, Ethidium bromide; AO, Acridine orange.
male and female reproductive systems (Trifunovic et al., 1995;
Basaria, 2010). At the physiological level, there are a wide range of
effects of AAS as they possess both anabolic, or muscle-building,
and androgenic, or masculinizing, properties (Kanayama et al.,
2007). For example, while AAS use in women is generally uncom-
mon, this population is highly vulnerable to the masculinizing
effects of AAS and any resulting reproductive changes (Malarkey
et al., 1991; Gruber and Pope, 2000; Kanayama et al., 2007). For
these reasons, since 1999 the committee of the Word Antidoping
Agency has been monitoring and regulating the use of AAS, along
with similar compounds classified as nutritional supplements
(http://www.wada-ama.org, The 2012 Prohibited List; and Carmo
et al., 2011).
AAS exert their effects in many parts of the body, including
the reproductive and endocrine tissues, muscle, bone, hair fol-
licles in the skin, the liver and kidneys, and the hematopoietic,
immune and central nervous systems (CNS) (Mooradian et al.,
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1987). For example, experiments carried out on human umbili-
cal vein endothelial cells to study the consequences of treatment
with high concentrations of some AAS have revealed significant
anti-proliferative effects, dramatically altered intracellular con-
centrations of calcium and induction of apoptosis (D’Ascenzo
et al., 2007). A major concern regarding AAS is their influ-
ence on behavior, which is often correlated with stroke, mood
disturbances, and psychotic symptoms (Uzych, 1992; Hall and
Chapman, 2005; Santamarina et al., 2008). In vivo administration
of high doses of androgens has been linked to neurobehavioral
changes like hyperexcitability, heightened aggressive behavior,
and suicidal tendencies (Tirassa et al., 1997; Thiblin et al., 2000).
There is evidence that some of this behavior could be caused by
the effects of AAS over synapse formation and function (Penatti
et al., 2009, 2011; Oberlander and Henderson, 2012). However,
particularly under conditions of high concentrations of testos-
terone and its metabolites, AAS may cause these changes as a
result of functional, morphological and biochemical effects on
neurons themselves, culminating in cell death (do Carmo et al.,
2012).
Inappropriate activation of apoptosis in neurons has
been associated with several neurological illnesses, including
Huntington disease and Alzheimer disease (AD) (Varshney
and Ehrlich, 2003; Tang et al., 2005). Non-physiological con-
centrations of AAS have been shown to induce neurotoxicity
over a long time course when in the presence of β-amyloid, an
important component of AD (Caraci et al., 2011). Most of the
CNS effects are of psychiatric origin, and whether or not AAS
are toxic to neurons is yet unknown. Orlando et al. studied the
effect of some AAS on excitotoxic neuronal death induced by
N-methyl-d-aspartate (NMDA) in primary cultures of mouse
cortical cells. Under these conditions, testosterone amplified
excitotoxic neuronal death at high concentrations (10μM)
(Orlando et al., 2007).
Given that AAS abuse poses a significant public health problem
and based upon the previously published data, we investigated
the morphological, biochemical and molecular mechanisms lead-
ing to changes in neuronal physiology, in particular neuronal cell
death, for supraphysiological concentrations of methandienone
and 17-α-methyltestosterone, two AAS commonly found for
sale on the internet and used for gain muscle mass but less
studied than other hormones such as nandrolone and andros-
terone. Derivates of methandienone and 17-α-methyltestosterone
also resist metabolism in the liver and contain modifications
that are associated with significant hepatic toxicities (Kuhn,
2002); of particular relevance, C17α-alkylated AAS, such as
17α-methyltestosterone, cannot be aromatized to 17β-estradiol
and can also inhibit aromatase activity. Supraphysiological levels
of 17α-methyltestosterone may promote diminished aromatiza-
tion (and thus estrogen levels) by directly inhibiting the activity
of this enzyme (Penatti et al., 2011).
There are a number of well characterized in vitro models that
have been used to examine chemical effects on neurite outgrowth
(Radio and Mundy, 2008). We chose to utilize the neuron-like
PC12 cell model. PC12 are a line that has been widely employed
in neurobiological investigations in order to evaluate the effects
of different drugs and potentially neurotoxic compounds on cell
morphology and physiology (Fujita et al., 1989; Vaudry et al.,
2002; Radio and Mundy, 2008). Following exposure to nerve
growth factor (NGF), PC12 cells differentiate into a sympathetic-
like neuron and develop extensive neuritic processes (Greene and
Rein, 1977), making this line an excellent model for evaluation of
environmental compounds on neurite outgrowth and differenti-
ation (Chan and Quik, 1993; Das and Barone, 1999; Lein et al.,
2000; Crumpton et al., 2001; Parran et al., 2003).
Here we demonstrate that rat neurons and PC12 cells express
the androgen receptor (AR). We describe a reduction in neurite
networks and loss of survival signaling and enhanced apoptosis,
as evidenced by a decrease in phospho-ERK and an increase in
the levels of the active fragment of caspase 3 and cleaved poly
(adenosine diphosphate [ADP]-ribose) polymerase (PARP), as
well as upregulation and cleavage of heat shock protein (Hsp) 90,
occurring in a dose-dependent manner in androgen treated PC12
differentiated in NGF. Many of these observations were noted
after long exposures of PC12 to AAS, suggesting a genomic effect,
and through the use of hydroxyflutamide we demonstrate that
AAS toxicity proceeds directly through the AR, likely altering gene
transcription to affect cell survival (Heinlein and Chang, 2002;
Nguyen et al., 2007). However, we also observed a short-term
increase in neuritin expression, an adaptive reaction seen in neu-
rons in response to injury. Taken together, these results suggest
that AAS may exert direct toxic effects on neurons of the CNS in
those abusing these substances in athletic training.
MATERIALS AND METHODS
CELL CULTURE AND HORMONE TREATMENT
Undifferentiated pheochromocytoma 12 cells (PC12, ATCC,
Manassas, VA) were cultured in RPMI-1640 medium contain-
ing 10% horse serum and 5% fetal bovine serum (Sigma-
Aldrich, St. Louis, MO). For induction of differentiation, cells
were grown in 12-well plates on poly-D-lysine (Sigma-Aldrich)
at an initial concentration of 1 × 105 cells per square cen-
timeter in a medium supplemented with 200 ng/ml of nerve
growth factor (NGF, Promega Corporation, Madison, WI) for
5 days. During this time, cells attached to the substratum and
produced a network of neurites. Differentiated PC12 cultures
were treated with vehicle (dimethyl ether, DME) or the steroid
hormones androsterone, nandrolone, methandienone and 17-α-
methyltestosterone (Cerilliant Corporation, Round Rock, Texas)
at a concentration of 50–75μM for times defined as short term
(24 h), and long term (48 h) (Duranti et al., 2011), and pre-
incubated for 2 h with vehicle control or 10μMhydroxyflutamide
(Sigma-Aldrich, St. Louis, MO) (Nguyen et al., 2007) where indi-
cated. Preliminary experiments verified that DME did not have
any effects compared to an evaluation of untreated cells (data not
shown).
IMMUNOHISTOCHEMISTRY
Immunohistochemistry on rat brain slices was performed fol-
lowing the protocol described previously (Basile et al., 2006).
The primary antibody was anti-AR (Santa Cruz, CA). Images
were acquired using a digital SPOT camera (SPOT Imaging
Solutions, Sterling Heights, MI) attached to an inverted Nikon
phase-contrast microscope (Nikon Instruments, Melville, NY).
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IMMUNOCYTOCHEMISTRY
Control or methandienone and 17-α-methyltestosterone treated
PC12 cells were fixed with 4% paraformaldehyde in PBS for
10min. on ice and subsequently permeabilized in cold methanol
for an additional 5min. After three washes with PBS, cells were
blocked with 5.5% FBS in PBS with 0.1%Triton X-100 for 45min.
at room temperature. The cells were then incubated with AR anti-
body (Santa Cruz, CA) in 3% BSA/ PBS overnight at 4◦C. The
next day, cells were washed three times in 0.1% Triton/ PBS and
once in PBS and incubated with biotinylated secondary antibody
(Dako North America, Carpinteria, CA) for 45min. Cells were
then washed three times in 0.1% Triton/ PBS and then once again
in PBS, followed by an incubation in 0.6% H2O2 for 30min. at
room temperature to quench endogenous peroxidase. Cells were
then incubated in strep ABC complex (Dako North America) at
room temperature for 30min, washed and incubated with DAB
peroxidase substrate (Vector Laboratories, Youngstown, OH) fol-
lowing manufacturer’s instructions. Counterstain was performed
in dilute Harris hematoxylin (Sigma-Aldrich). Image acquisi-
tion was performed as described for immunohistochemistry (see
above).
IMMUNOFLUORESCENCE AND ANALYSIS OF NEURITE NETWORK
1 × 105 PC12 cells per square centimeter growing on poly-
D-lysine coated cover slips were differentiated for 5 days in
200 ng/ml of NGF (Promega), followed by treatment with 75μM
of methandienone or 17-α-methyltestosterone (Cerilliant) or
equal amounts of DME (as the carrier control). Cells were
then fixed with 96% ice-cold ethanol for 10min. and perme-
abilized for 5min. with 0.1% Triton X-100 in PBS. Cells were
blocked in 3% fetal bovine serum for 30min., followed by 1 h
incubation in a humidity chamber at room temperature with
rabbit polyclonal anti-NF antibody (Cell Signaling Technology,
Beverly, MA). The secondary antibody was anti-rabbit IgG conju-
gated to fluorescein (Sigma Aldrich). The samples were mounted
with Vectashield mounting medium containing 4-6-diamino-2-
phenyl-indole (DAPI, Vector Laboratories). Morphological anal-
ysis and quantification of neurite bearing cells were carried out
using an Aperio Scanscope (Aperio Technologies, Vista, CA). Ten
randomly separated microscopic fields were observed and the
proportion of cells with neurites equal to or greater than the
length of one cell body were scored positive for neurite out-
growth, with the final result expressed as a percentage of the total
number of cells counted. Neurite extension length was also mea-
sured for all identified positive neurite bearing cells per field by
tracing the longest length neurite using the Neuron J module of
Image J software (NIH, Bethesda, MD, version 1.46c). The value
of neurite length in pixels (average maximal neurite length per
neurite-bearing cell in 10 fields) was calculated and designated
as one experiment. All experiments were repeated at least three
times on separate days and data are expressed as mean ± SD.
VITALITY ASSAY
Cell death was evaluated by staining PC12 cells treated
for 48 h with 75μM methandienone, 17-α-methyltestosterone
or DME with acridine orange/ethidium bromide mixture
(Sigma-Aldrich), each at a concentration of 100μg/ml in PBS as
previously described (Schiera et al., 2007). Cells were observed
with a Fluoview FV1000 Confocal Microscope (Olympus).
WESTERN BLOT ANALYSIS
After the indicated treatment, cells were collected, washed
with PBS, and homogenized in lysis buffer (Cell Signaling
Technology) supplemented with protease inhibitors (0.5mM
phenylmethylsulfonyl fluoride, 1μl/ml aprotinin and leupeptin,
Sigma-Aldrich) and phosphatase inhibitors (2mM NaF and
0.5mM sodium orthovanadate, Sigma-Aldrich). After centrifu-
gation, protein concentrations were measured using the Bio-
Rad protein assay (Bio-Rad Hercules, CA). 15μg of protein
was loaded onto each lane of 12% acrylamide-SDS denaturing
gels. After electrophoretic separation, samples were electroblot-
ted onto a PVDF membrane (Immobilon P, Millipore Corp.,
Billerica, MA). The blotting membrane was blocked with 5%
milk and then immunostained with one of the following anti-
bodies: anti-phospho-ERK (Cell Signaling Technology); rabbit
polyclonal anti-Hsp90 (Cell Signaling Technology); rabbit poly-
clonal anti-cleaved caspase 3 (Cell Signaling Technology); rabbit
polyclonal anti-PARP (Cell Signaling Technology); anti-GAPDH
(Sigma-Aldrich).
RNA EXTRACTION, REVERSE TRANSCRIPTION AND REAL TIME-PCR
ANALYSIS
RNA was extracted from treated and untreated PC12 cells using
the TRIZOL reagent (Life Technologies, Grand Island, NY)
according to the protocol provided by the manufacturer. After the
last step of the protocol, the RNAwas air-dried and then dissolved
in RNAase free water for quantification by spectrophotometer.
1μg of RNAwas used for reverse transcription to cDNA using the
AMV reverse-transcriptional system (Promega) in the presence of
randomhexamers (Invitrogen, Life Technologies). The cDNAwas
used for quantitative real-time PCR (RT-qPCR) with specific gene
primers as follows: Neuritin sense: 5′-gcatctggtgaataatcgctcacg-3′ ,
anti-sense: 5′-actgaaggaggcgacgacaatagc-3′; GAPDH sense:
5′-atcccatcaccatcttccag-3′ , anti-sense: 5′-cctgcttcaccaccttcttg-3′ .
The CT method was used for data analysis of neuritin mRNA
expression, estimated in triplicate samples and normalized to
GAPDH expression levels.
STATISTICAL ANALYSIS
Student’s paired t tests were performed on means, and p values
calculated: ∗, p ≤ 0.05; ∗∗, p ≤ 0.01.
RESULTS
AR IS EXPRESSED IN NEURON-LIKE PC12 CELLS
The AR, a member of the nuclear receptor superfamily
of transcription factors, is capable of binding the prin-
cipal steroidal androgens testosterone and its metabolite
5α-dihydrotestosterone, as well as other AAS, and mediating
their effects within the cell (Lee and Chang, 2003). Caraci
et al. determined that neurons express this receptor (Caraci
et al., 2011), results we confirmed in an immunohistochemical
analysis for AR in rat cerebellum (Figure 1A) and brain stem
(Figure 1B). To determine if PC12 cells also express this receptor
after differentiation and induction of a neuron-like phenotype,
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FIGURE 1 | Immunohistochemistry in Purkinje cells of the rat
cerebellum demonstrates expression of AR. Original magnification 200 X
(A). AR expression in neurons of the rat brain stem. Original magnification
200 X (B). Immunocytochemistry for AR on PC12 in culture. Details of
receptor expression are shown in the inset. Original magnification 200 X (C).
AR expression in PC12 cells. Original magnification 400 X (D).
we performed immunocytochemistry for AR on NGF treated
PC12 in culture. We observed AR expression in the cytoplasm
(Figure 1C), which under higher magnification exhibited a
peri-nuclear pattern of expression (Figures 1C, inset, and 1D),
contrary to a prior report (Nguyen et al., 2005) but in accordance
with others (Gehlhaus et al., 2007; Meyer et al., 2009). These
results indicate that PC12 express the receptor for androgens that
could be mediating the pathway for AAS to affect cell physiology.
METHANDIENONE AND 17-α-METHYLTESTOSTERONE INHIBIT
NEURITE NETWORKS
Neuron cell cultures are a useful system to study potential delete-
rious effects of different compounds. In this model, alterations
in sprout formation and neurite length are used as a deter-
minant of neurotoxicity (Radio and Mundy, 2008). Since cul-
turing PC12 cells in NGF induces formation of neurites, we
used this model to determine the effects of methandienone and
17-α-methyltestosterone on neurons, growing treated cells in
control media or media containing 50 or 75μM of these AAS
and observing effects on differentiated PC12 neurite outgrowth.
While untreated cells exhibited prominent neurite maintenance
(Figure 2A, left panel), cells treated with both methandienone
(center panel) and 17-α-methyltestosterone (right panel) lost this
phenotype. Quantification of loss of neurite formation is shown
in Figure 2B. Both of these AAS also resulted in dramatic reduc-
tion of the total length of all neurites observed, relative to vehicle
controls (Figure 2C). Taken together, the results suggest that
these AAS can exert toxic effects on neuronal networks, inducing
neurite loss and neuronal network damage.
METHANDIENONE AND 17-α-METHYLTESTOSTERONE INDUCE DEATH
OF PC12 CELLS
To further determine toxicity, PC12 were grown in 75μM of
methandienone and 17-α-methyltestosterone and examined for
cell death in a vitality assay. In this system, cells are analyzed by
immunofluorescence to detect membrane integrity based upon
the uptake or exclusion of a dye from the cell. Ethidium bro-
mide (EB) fluoresces red and is only able to pass through the
membrane of a dead or dying cell, while acridine orange (AO),
which fluoresces green, is a membrane-permeable dye that will
stain all cells in the sample. Cells fluorescing yellow are taking
up both EB and AO and represent an early stage of cell death,
with a more orange color indicating a later stage in the pro-
cess. We observed that most control treated, differentiated PC12
remained vital (Figure 3A, left panel) while cells treated with
both methandienone (center panel) and 17-α-methyltestosterone
(right panel) exhibited prominent increases in indicators of early
and late cell death (see insets). When quantified, we observed
slightly more cell death in PC12 growing in the presence of 17-
α-methyltestosterone when compared to equal concentrations
of methandienone (Figure 3B). These results suggest that both
methandienone and 17-α-methyltestosterone are toxic to neu-
rons, inducing death in treated cells.
AAS INDUCE APOPTOSIS IN PC12
To confirm that the cell death we observed was apoptosis, and to
compare with other AAS to determine if this could be a general
mechanism of toxicity for a variety of androgens, we examined by
immunoblot for levels of active, phosphorylated ERK, an indica-
tor of cell survival. TheMAPK cascade, and in particular ERK, has
been shown to be protective in neuronal cell types, allowing them
to survive exposure to pro-apoptotic compounds (Karmarkar
et al., 2011). Therefore, decreases in phospho-ERKmight indicate
progression to cell death. We observed decreases in levels of phos-
phorylated ERK protein following treatment with androsterone,
nandrolone, methandienone and 17-α-methyltestosterone, com-
pared to controls (Figure 4A, upper panel). We also looked for the
appearance of cleaved and hence active caspase 3 as an indicator
of apoptosis, cleaved PARP (a caspase target), and cleavage of heat
shock protein (Hsp) 90, a chaperone involved in the normal fold-
ing of various polypeptides that has been shown to be degraded
in cells undergoing apoptosis and that associates with the AR
(Chen et al., 2008, 2009), following treatment with the same
AAS. We noted upregulation of the active fragment of caspase 3,
an indication of activation of the caspase cascade, occurring in
response to all AAS used (Figure 4B, upper panel). Additionally,
we observed the appearance of cleavage products for PARP and
Hsp90 (Figure 4B, middle panels), proteins that are downstream
targets of caspases in apoptosis. These results suggest that neu-
ronal cell death may contribute to some of the CNS symptoms
observed with long-term use of AAS.
Examining methandienone and 17-α-methyltestosterone in
more detail, we noted upregulation of the active fragment of
caspase 3 occurring in a dose dependent manner following treat-
ment of both of these AAS (Figure 4C, top panels), along with the
appearance of cleaved PARP and Hsp90 (Figure 4C, middle pan-
els). GAPDH was used as a loading control for all blots (bottom
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FIGURE 2 | Immunofluorescence for neurofilament to demonstrate
neurite outgrowth in PC12 cells differentiated in NGF in tissue
culture, either control treated (left panel), treated with 75μM
methandienone (center panel) or treated with 75μM of
17-α-methyltestosterone (right panel) (A). Quantification of neurite
outgrowth in the three conditions shown in (A), as determined by cells
exhibiting neurites equal to or greater than the length of one cell body,
as a percentage of the total number of cells counted (Y-axis).
Experiments were repeated at least three times and data expressed as
mean ± SD (∗∗P ≤ 0.01). These AAS demonstrate toxic effects on
formed neurite networks in differentiated PC12 (B). Average of the sums
of neurite length for identified neurite bearing cells in 10 high-power
fields (Y-axis). Experiments were repeated at least three times and data
expressed as mean ± SD (∗∗P ≤ 0.01) (C).
panels). Similar to the cell death response in the vitality assay,
we observed slightly more pronounced indicators of apoptosis
in the immunoblot for cells treated with 17-α-methyltestosterone
compared to methandienone. Taken together, these results sug-
gest that methandienone and 17-α-methyltestosterone are toxic to
neuron-like cells at least in part through activation of apoptosis.
METHANDIENONE AND 17-α-METHYLTESTOSTERONE PROMOTE
APOPTOSIS THROUGH THE AR
To determine if apoptosis proceeds through the AR, we treated
cells with methandienone and 17-α-methyltestosterone but this
time in the presence of the anti-androgen hydroxyflutamide
(Nguyen et al., 2007). We again observed evidence of cleav-
age fragments of caspase 3, PARP and Hsp90, but loss of
these biochemical indicators of apoptosis when incubated with
hydroxyflutamide (Figures 5A,B). This result suggests that the
AR mediates the apoptotic effects of these AAS, though further
experiments will be necessary to investigate this mechanism in
greater detail.
METHANDIENONE AND 17-α-METHYLTESTOSTERONE PROMOTE AN
INCREASE IN mRNA LEVELS OF NEURITIN
Neuritin is a neurotrophic factor that plays an important role
in neurite growth and survival. It is known to be upregulated
in damaged, stressed or ischemic neurons as they attempt to
re-establish connectivity following injury (Ujike et al., 2002).
Other groups have shown that certain steroids can act through
the AR, which we have demonstrated is expressed in differen-
tiated PC12 (Figure 1), to increase neuritin expression (Fargo
et al., 2008). Therefore, we looked at neuritin mRNA levels in
differentiated PC12 treated with increasing concentrations of
methandienone and 17-α-methyltestosterone for 24 h. In these
conditions, we observed a dose dependent increase in neuritin
mRNA levels for both AAS tested with 17-α-methyltestosterone,
which induced more cell death in the vitality assay, promot-
ing a more dramatic upregulation of neuritin mRNA (Figure 6).
These results anticipated suppression of neurite outgrowth and
cell death, which were observed after 2 days of treatment, sug-
gesting an adaptive response on the part of the cell to resist
AAS toxicity.
DISCUSSION
There are great challenges in attempting to characterize the
potential risks of neurotoxicity for environmental chemicals
and pharmacological agents such as AAS. Indeed, among the
innumerable commercial compounds available, a relative few
have been adequately characterized for their potential effects on
human health in general, and fewer still specifically tested for
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FIGURE 3 | PC12 cells were control treated (left panel) or treated with
75μM methandienone (center panel) or 75μM 17-α-methyltestosterone
(right panel) for 48h and a vitality assay was performed. Green cells are
vital; cells in early cell death are yellow; orange indicates late cell death (A).
Vitality status expressed as percentage of total live cells counted in 10 high
power fields (Y-axis) reveals that methandienone and 17-α-methyltestosterone
induce cell death in PC12. Experiments were repeated at least three times
and data expressed as mean ± SD (∗P ≤ 0.05) (B).
neurotoxicity. It is important to note that the number of studies
with rigorous scientific methodology that have derived significant
conclusions is small, whereas the intensity of the underground
marketing and promotion of most AAS is intense, far exceeding
the data supporting their use. At the same time it is important to
note that non-hormonal supplements, such as vitamins, amino
acids, caffeine and ephedrine often contain anabolic steroids that
are not declared on the labels of the products. The most abun-
dant steroids found in these supplements are methandienone and
17-α-methyltestosterone.
It has been suggested that tests based on a variety of
in vitro assessments may be useful as a screen to identify neu-
rotoxic substances. We employed several cell biological and bio-
chemical techniques to demonstrate that methandienone and
17-α-methyltestosterone were damaging neuron-like differenti-
ated PC12 cells through inhibition of neurite networks and
apoptosis, suggesting that administration of these AAS for the
purpose of enhancing athletic performance could put the user
at risk for even more potentially harmful side effects in addition
than the better known effects on the endocrine, musculo-skeletal,
and reproductive systems.
The development of the CNS involves coordinated gene
expression and an ordered initiation of specific cellular events
regulating proliferation, differentiation, cell migration, neurite
outgrowth, synapse formation, myelination, and programmed
cell death. Theoretically, chemically mediated disruption of one
or more of these events could potentially impair CNS develop-
ment or function (Barone et al., 2000). Neurite outgrowth in
particular involves many of these processes, including the differ-
entiation of precursor cells to a terminal neuronal phenotype and
the initiation and development of broad, sheet-like extensions
(lamellipodia) which subsequently condense into short cytoplas-
mic processes capable of communicating with neighboring cells
through synaptogenesis (Craig and Banker, 1994). Alterations in
neuronal signaling and synapse formation likely contribute to the
outward psychological and behavioral manifestations of steroid
use (Penatti et al., 2009, 2011; Oberlander and Henderson, 2012).
However, while synapse signaling is one of the first processes to
be affected in the premature aging model, for example, neuron
degeneration is known to underly many behavior disorders (de
Graaf et al., 2013). Therefore, we limited our study to morphol-
ogy and cell death utilizing the PC12 cell model. PC12s are a well
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FIGURE 4 | Immunoblots demonstrate decreasing levels of phospho-ERK
(top panel) in PC12 treated for 48 h with 75μM androsterone,
nandrolone, methandienone, and 17-α-methyltestosterone, compared to
control treated cells (A). Immunoblots for caspase 3 (top panel), PARP
(second panel), and Hsp90 (third panel) in PC12, control treated or treated
48 h with 75μM androsterone, nandrolone, methandienone, and
17-α-methyltestosterone demonstrate increasing levels of the activated
fragment of caspase 3 and cleavage of PARP and Hsp90, indications of
apoptosis and cell death (B). PC12 were control treated or treated for 48 h
with 50 or 75μM methandienone (left column) or 17-α-methyltestosterone
(right column). Increasing concentrations of these AAS resulted in
appearance of the activated fragment of caspase 3 and cleavage of PARP and
Hsp90 in a dose-dependent manner (C). GAPDH was used as the loading
control for all blots (bottom panels).
characterized in vitro model for evaluation of chemical neurotox-
icity because they differentiate into a sympathetic-like neurons
and develop extensive neuritic projections following exposure to
NGF (Fujita et al., 1989; Vaudry et al., 2002; Radio and Mundy,
2008). Many studies have used PC12 cells to evaluate the effect of
environmental chemicals on neurite outgrowth (Chan and Quik,
1993; Das and Barone, 1999; Lein et al., 2000; Crumpton et al.,
2001; Parran et al., 2003). Using this model, both neuroprotec-
tive (Fargo et al., 2008) and neurodegenerative effects (Radio and
Mundy, 2008) of androgens have been described. In the present
study, we investigated the effects of supraphysiological amounts of
two different AAS, methandienone and 17-α-methyltestosterone,
and observed dramatic changes in the sympathetic neuron-like
PC12 cell line.
The concentrations of steroids used in our experiments
are comparable to that used in other studies examining dif-
ferent compounds considered to be performance-enhancing.
For example, in Duranti’s study, rat L6C5 and mouse C2C12
skeletal muscle cells were treated with up to 20μM of the
β2-adrenergic receptor agonist salmeterol at a concentration
of 1 × 104 cells per square centimeter, conditions compara-
ble to our AAS experiments (Duranti et al., 2011). Indeed,
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FIGURE 5 | Immunoblots for caspase 3 (top panel), PARP (second
panel) (A) and Hsp90 (B) in PC12, control treated or treated for 48h
with 75 μM methandienone and 17-α-methyltestosterone alone or
with 10μM hydroxyflutamide. Indicators of apoptosis are decreased in
the presence of hydroxyflutamide. GAPDH was used as the loading control
for all blots (bottom panels).
FIGURE 6 | Levels of neuritin mRNA (CT , Y-axis) in PC12 treated for
24 h in the indicated concentrations of AAS, as determined by RT-qPCR
normalized to GAPDH, reveal a dose-dependent increase in
transcription. Experiments were repeated three times and data expressed
as mean ± SD (∗P ≤ 0.05; ∗∗P ≤ 0.01).
the initial concentration of cells per square centimeter used
in our studies is the minimum required to allow neuron-like
cells to create a neurite network. Our results demonstrate that
methandienone and 17-α-methyltestosterone are detrimental to
the development of neuron-like characteristics in PC12 cells, and
therefore could be considered to have a high risk of neurotoxic-
ity in vivo. As a result, these compounds will likely require further
testing.
AAS that previously had been shown to damage neurite net-
works in PC12 cells have also been shown to activate the apoptotic
pathway. Having detected evidence of toxicity in the neurite out-
growth assay, we then wanted to determine if the continued
exposure of differentiated PC12 to AAS might induce cell death.
Therefore, we examined PC12 cells in a vitality assay and observed
evidence of permeability to an acridine orange/ethidium bromide
mixture, and hence loss of membrane integrity and cell death, fol-
lowing exposure to methandienone and 17-α-methyltestosterone,
with the latter showing slightly more cell death than the for-
mer. To determine the nature of cell death, we investigated
phospho-ERK, a marker of ell vitality and survival, and sev-
eral components of the apoptotic pathway. Phosphorylation of
ERK was reduced upon exposure to androsterone, nandrolone,
methandienone and 17-α-methyltestosterone. Caspase 3 is one
of the key executioners of apoptosis, engaging in the proteolytic
cleavage of many key proteins such as the nuclear enzyme PARP.
Indeed, the finding that caspase 3 is expressed in PC12 sug-
gests a role for this protease in PC12 cell death (Haviv et al.,
1997). We detected the appearance of the cleaved and hence
active form of caspase 3, along with the cleaved form of PARP,
in an immunoblot of PC12 exposed to all AAS tested, sug-
gesting that apoptosis might be a generalized response to high
concentrations of steroids.When usingmethandienone and 17-α-
methyltestosterone, dose dependent increases in these indicators
of apoptosis were seen, with a slightly more dramatic response for
the same given concentrations of 17-α-methyltestosterone. Taken
together, these results demonstrate that AAS induce apoptosis in
neuritized PC12.
We noted that the effects on cells following AAS treatment
were delayed, suggesting that these hormones might exert their
effects by acting on AR-mediated genomic pathways. Though pre-
vious efforts have failed to detect the AR receptor in PC12 cells
by RT-PCR (Nguyen et al., 2005), we did in fact demonstrate AR
receptor expression in both rat brain (as a control) and in neuron-
like PC12 cells growing in culture, supporting the findings of
other investigators (Gehlhaus et al., 2007; Meyer et al., 2009) and
in a distribution pattern similar to that identified through confo-
cal microscopy in prior publications (Caraci et al., 2011). While
androgens can exert rapid non-genomic effects involving induc-
tion of second messenger signal transduction cascades, these
lipophilic hormones also induce AR dimerization and transloca-
tion into the nucleus where the complex engages in direct protein-
protein interaction with transcriptional co-regulators at cognate
palindromic response elements to promote the expression of tar-
get genes. The presence of AR in PC12 and the delayed responses
we observed support a possible genomic influence on cell viabil-
ity for the AAS (Imperlini et al., 2010). Therefore, to investigate
if the mechanism proceeds through AR stimulation, we treated
cells with methandienone and 17-α-methyltestosterone alone or
with the anti-androgen hydroxyflutamide. Loss of indicators of
apoptosis in the presence of hydroxyflutamide suggest that AAS-
mediated apoptosis proceeds through the AR and might therefore
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alter gene transcription (Heinlein and Chang, 2002). However,
further detailed study is required.
Hsp90 is a molecular chaperone responsible for controlling
numerous signaling pathways in the cell (Bishop et al., 2007). It
is essentially a protective protein, keeping pro-apoptotic factors
in an inert state while simultaneously regulating anti-apoptotic
proteins (Lewis et al., 2000). Other studies have shown that cleav-
age of Hsp90 correlates with activation of apoptosis through both
the intrinsic or mitochondrial-mediated death pathway as well
as through extrinsic or receptor-mediated pathways (Arya et al.,
2007; Chen et al., 2009). Our studies support these conclusions
with the observation of the appearance of a cleaved fragment of
Hsp90 following treatment of PC12 cells with methandienone
and 17-α-methyltestosterone.
We also observed a dose-dependent increase in neuritin
mRNA levels in PC12 cells treated with methandienone and
17-α-methyltestosterone, which to our knowledge is the first
in vitro evidence of androgen-mediated regulation of neuritin
mRNA levels in PC12 cells. Neuritin is a gene that regulates
androgen-induced (and AR-dependent) neurite outgrowth in
motor neurons, usually in response to an injury. In cultured
cells, recombinant neuritin protein enhances neurite extension
and branching (Naeve et al., 1997). However, unlike in these prior
reports, we show that neuritin increases occurred prior to the vis-
ible manifestations of loss of neurite formation and cell death.
This discrepancy could be attributable to the concentrations of
AAS used in our study, which were an attempt to approximate
the amounts used by athletes to enhance performance, or dif-
ferences in cell type and experimental conditions. We regarded
increased production of this neurotrophic factor as a response to
stress and an attempt at cell survival, as continued exposure to
methandienone and 17-α-methyltestosterone eventually induced
apoptosis. In contrast to our other findings, methandienone
elicited a less significant response in this assay (a lower increase in
neuritin mRNA) when compared to administration of the same
amounts of 17-α-methyltestosterone. If 17-α-methyltestosterone
truly is more harmful to neuron-like cells than methandienone, as
suggested by the vitality assay and apoptosis immunoblots, then
it could have promoted higher levels of neuritin transcription as
an adaptive response to resist the greater toxicity for this AAS. The
differences we observed in PC12 responses to methandienone and
17-α-methyltestosterone as well as protein expression patterns
warrant further investigation.
Here we show that at high concentrations, methandienone and
17-α-methyltestosterone exert detrimental effects on differenti-
ated PC12 cells expressing AR, including inhibition of neurite
network maintenance, induction of cell death through apop-
tosis and cleavage of the protective chaperone protein Hsp90.
Between these two compounds we noted greater cell death and
higher neuritin transcription in PC12 in response to 17-α-
methyltestosterone treatment, supporting the belief that this AAS
is themore toxic to neuron-like cells of the two compounds tested.
These findings will be pursued in future investigations but cur-
rently suggest another potentially harmful physiological effect in
the abuse of steroids, that of CNS toxicity.
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